Thrombolytic Therapy: Evidence-Based Results from Multicenter Control Trials
Years Author Number of patients 1970–2000 UPETSG (1970) 160 Tibbutt et al. (1974) 30 Ly et al. (1978) 25 Marini et al. (1988) 30 Levine et al. (1990) 58 PIOPED…
Years Author Number of patients 1970–2000 UPETSG (1970) 160 Tibbutt et al. (1974) 30 Ly et al. (1978) 25 Marini et al. (1988) 30 Levine et al. (1990) 58 PIOPED…
Level A: Multiple populations evaluated. Data derived from multiple randomized clinical trials or meta-analyses Level B: Limited populations evaluated. Data derived from a single randomized trial or nonrandomized studies Level…
Fig. 7.1 Modified of C Jerjes Sanchez y cols. Ischemic cascade that are generated from a massive PE over the right ventricle, and the phenomena that can increase or reduce…
Intervention Indications Cautions Side effects Protocol Notes Supranormal elevation of oxygen delivery Critically ill patients at increased risk of death Patients not responding to initial challenge have a worse prognosis…
1st author/year N Durationof study Participants Therapeutic intervention Control intervention Follow-up time Conclusion HACA/2002 [5] 275 65 m Unconscious OHCA patients, cardiac cause of arrest (initial rhythm VF or non-perfusing…
Inclusion criteria 1. Published in peer-reviewed journal 2. Multicenter randomized design 3. Dealt with a nonsurgical intervention (drug/technique/strategy) 4. Involving adult critically ill patients 5. Showing a statistically significant reduction…
Drug Indications Contraindications Side effects Dose Note Glutamine (alanyl-glutamine and glycine-glutamine) Critically ill patients (intensive care unit patients, burns, surgical patients) Bone marrow transplant Weight loss in patients with AIDS…
Technique Indications Contraindications Side effects Protocol Note High-frequency oscillatory ventilation (HFOV) Acute respiratory distress syndrome with hypoxemia refractory to conventional protective ventilation Recent lung surgery, lung disease characterized by airway…
Fig. 13.1 Schematic diagram showing the scientific rationale and potential role of β2-agonists in ARDS (Adopted from: Bassford et al. [13]. Permission to reproduce granted under BioMed Central’s general terms)…
Always available without temperature limitations Long shelf life Effective oxygen-carrying capacity Effective volume expander Absent scavenging effect on nitric oxide No side effects No infectious carrier No crossmatching necessity Cost-effective…